51 JFK Parkway, Short Hills, NJ 07078
Category

DEA Investigations

DEA inspections, controlled substance compliance, and Drug Supply Chain Security Act enforcement.

Page 5 of 5 · 45 articles
Collateral Consequences Mount Quickly After Adverse DEA Inspection
DEA Investigations

Collateral Consequences Mount Quickly After Adverse DEA Inspection

Adverse findings during a DEA inspection can trigger a chain reaction of serious consequences for pharmacies, including increasing…

Diana YastrovskayaAug 13, 2025
DEA Registration Requirements for Healthcare Providers: How to Stay Compliant
DEA Investigations

DEA Registration Requirements for Healthcare Providers: How to Stay Compliant

Understanding DEA registration requirements is crucial for healthcare providers handling controlled substances. Compliance with st…

Diana YastrovskayaMay 12, 2025
Should You Voluntarily Surrender Your DEA Registration? What Healthcare Professionals Need to Know
DEA Investigations

Should You Voluntarily Surrender Your DEA Registration? What Healthcare Professionals Need to Know

Considering voluntarily surrendering your DEA registration? Our experts can help you navigate the process and understand your opti…

Diana YastrovskayaMay 7, 2025
A Step-by-Step Guide to Securing (and Keeping) Your DEA Registration
DEA Investigations

A Step-by-Step Guide to Securing (and Keeping) Your DEA Registration

Learn how to obtain and protect your DEA registration with our step-by-step guide, updated for 2025 telehealth rules and audit tre…

Diana YastrovskayaFeb 12, 2025
DEA Inspections Overview: What to Expect and How to Prepare for a DEA Inspection
DEA Investigations

DEA Inspections Overview: What to Expect and How to Prepare for a DEA Inspection

Learn what to expect during DEA inspections and how to protect your practice with proactive preparation strategies.

Diana YastrovskayaDec 13, 2024
DEA and HHS Extend COVID-19 Telehealth Prescribing Flexibilities Through 2025
DEA Investigations

DEA and HHS Extend COVID-19 Telehealth Prescribing Flexibilities Through 2025

Discuss the DEA/HHS joint rule extending the prescribing flexibilities for controlled substances. Include: 1) an overview of the p…

Anthony MahajanNov 29, 2024
Increased Scrutiny for DEA Registration Applications
DEA Investigations

Increased Scrutiny for DEA Registration Applications

DEA registration applications are receiving increased scrutiny as DEA turns its sights on providers and pharmacies to curtail cont…

Anthony MahajanMay 4, 2024
Pharmacy Alert: Texas Board of Pharmacy Investigations
DEA Investigations

Pharmacy Alert: Texas Board of Pharmacy Investigations

Texas pharmacies are facing increasing scrutiny by the Board of Pharmacy, which is working closely with the DEA and other federal…

Anthony MahajanMar 22, 2024
DEA's Dangerous New Agenda
DEA Investigations

DEA's Dangerous New Agenda

Although DEA has long targeted wholesalers as the "choke-point" for stemming diversion, the Agency has now shifted its focus to do…

Anthony MahajanJan 16, 2024